Methicillin - PDFSEARCH.IO - Document Search Engine

Methicillin
Results: 3536

#	Item
921	NATIONAL STRATEGY FOR COMBATING ANTIBIOTICRESISTANT BACTERIA Vision: The United States will work domestically and internationally to prevent, detect, and control illness and death related to infections caused by antibiot Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2015-01-23 13:04:30 Antibiotics Bacterial diseases Veterinary medicine Pathogenic bacteria Antibiotic resistance Antibacterial Antimicrobial Methicillin-resistant Staphylococcus aureus Drug resistance Bacteria Microbiology Biology
922	NIC Bulletin Official Newsletter of the National-Interstate Council of State Boards of Cosmetology, Inc. September/ October 2006 Add to Reading List Source URL: www.nictesting.org Language: English - Date: 2014-08-15 15:17:52 Bacterial diseases Infectious diseases Hygiene Staphylococcaceae Microbiology Cosmetology Methicillin-resistant Staphylococcus aureus Infection control Nail Medicine Health Bacteria
923	Microsoft Word - EN_MRSA FINAL[removed]docx Add to Reading List Source URL: www.ammi.ca Language: English - Date: 2015-01-13 14:51:59 Staphylococcaceae Bacterial diseases Antibiotic-resistant bacteria Methicillin-resistant Staphylococcus aureus Microbiology Occupational diseases Staphylococcus aureus Antibiotic resistance ST8:USA300 Medicine Bacteria Health
924	NAME OF AGENCY CDC’s Healthcare-Associated Infection Progress Report: Questions and Answers Tracking Healthcare-Associated Infections Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2014-08-13 14:47:27 Healthcare Patient safety Patient safety organization Nosocomial infection Methicillin-resistant Staphylococcus aureus Infection control Medicine Health Infectious diseases
925	Theravance and Astellas to Collaborate on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/ November 7, [removed]Theravance, Inc., and Astellas Pharma Inc. announced t Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:56:16 Pharmacology Astellas Pharma Medicine Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Vancomycin Antibiotics Telavancin Pharmaceutical sciences
926	Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections SOUTH SAN FRANCISCO, CA and DEERFIELD, IL/OCTOBER 22, 2007 – Theravance, Inc. (NASDAQ: THRX) Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:34:44 Pharmaceutical sciences Health Astellas Pharma Methicillin-resistant Staphylococcus aureus Skin and skin structure infection Food and Drug Administration Antibiotics Telavancin Medicine
927	JUNE 07 Web Newsletter V5 Add to Reading List Source URL: isid.org Language: English - Date: 2012-07-17 12:53:05 ProMED-mail Disease surveillance Infectious disease Centers for Disease Control and Prevention Infection control Methicillin-resistant Staphylococcus aureus Infection Epidemiology Medicine Health
928	Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe TOKYO, JAPAN AND SOUTH SAN FRANCISCO, CA/October 28, 2009 Add to Reading List Source URL: www.astellas.com Language: English - Date: 2009-10-28 20:07:57 Bacterial diseases Antibiotics Staphylococcaceae Pathogenic bacteria Telavancin Glycopeptide antibiotics Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Astellas Pharma Bacteria Microbiology Medicine
929	Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/July 18, [removed]Theravance, Inc. (NASDAQ: THRX), and Astellas Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:50:37 Astellas Pharma Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Pharmacology Medicine Antibiotics Telavancin Pharmaceutical sciences
930	Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe TOKYO, JAPAN AND SOUTH SAN FRANCISCO, CA/May 1, 2007 – Astellas Pharma Inc. (Aste Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:25:49 Astellas Pharma Pharmaceutical industry Methicillin-resistant Staphylococcus aureus Pharmacology Medicine Antibiotics Telavancin Pharmaceutical sciences

UPDATE